/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

David P. Rosenbaum

Ardelyx (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

116

Papers

2.7K

Citations

26

h-index

47

i10-index

David P. Rosenbaum is an academic researcher from Ardelyx (United States). The author has contributed to research in topics: Parathyroid Disorders and Treatments & Gastrointestinal motility and disorders & Magnesium in Health and Disease. The author has an h-index of 26, co-authored 99 publications.

ORCID: 0000-0002-9371-391X

Research Topics

Parathyroid Disorders and Treatments Gastrointestinal motility and disorders Magnesium in Health and Disease Potassium and Related Disorders Ion Transport and Channel Regulation

Papers by this author

works

The Changing Landscape for Stroke Prevention in AF

2017 · Journal of the American College of Cardiology · 280 citations

https://doi.org/10.1016/j.jacc.2016.11.061

Menno V. Huisman Kenneth J. Rothman Miney Paquette Christine Teutsch

A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients

2015 · BMC Nephrology · 61 citations

https://doi.org/10.1186/s12882-015-0110-9

Claudia Cabrera Steven M. Brunelli David P. Rosenbaum Emmanuel A. Anum

Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure

2024 · Journal of Renal Nutrition · 10 citations

https://doi.org/10.1053/j.jrn.2024.07.003

Kathleen M. Hill Gallant Stuart M. Sprague David P. Rosenbaum David M. Spiegel

Tenapanor Improves Abdominal Symptoms Irrespective of Changes in Complete Spontaneous Bowel Movement Frequency in Adults with Irritable Bowel Syndrome with Constipation

2024 · Digestive Diseases · 4 citations

https://doi.org/10.1159/000543166

Darren M. Brenner Gregory S. Sayuk Brooks D. Cash Lucinda A. Harris

POS-289 A LONG-TERM STUDY TO EVALUATE TENAPANOR'S ABILITY, ALONE OR IN COMBINATION WITH SEVELAMER, TO ACHIEVE NORMAL SERUM PHOSPHORUS IN PATIENTS WITH CKD ON DIALYSIS (NORMALIZE)

2021 · Kidney International Reports · 0 citations

https://doi.org/10.1016/j.ekir.2021.03.304

David P. Rosenbaum A.L. Silva Yong Yang Geoffrey A. Block

Tu1663 COMPARING THE EFFICACY OF TENAPANOR IN IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN HISPANIC VS NON-HISPANIC PATIENTS: A POST HOC ANALYSIS OF PATIENTS IN THE PHASE 3 T3MPO-1 AND T3MPO-2 STUDIES

2024 · Gastroenterology · 0 citations

https://doi.org/10.1016/s0016-5085(24)03600-x

Rosita Frazier Yang Yang Susan Edelstein William L. Hasler

Research topics

topics

Parathyroid Disorders and Treatments

Gastrointestinal motility and disorders

Magnesium in Health and Disease

Potassium and Related Disorders

Ion Transport and Channel Regulation

Chat about Author

Papers

Chat

Click to start Chat